4.6 Article

Role of COL6A2 in malignant progression and temozolomide resistance of glioma

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

Sandipan Datta et al.

Summary: GBM tumors contain glioma stem-like cells (GSCs) and differentiated GBM cells (d-GCs) with differences in mitochondrial metabolism. Inhibiting mitochondrial function selectively targets GSCs and may offer a potential therapeutic option for GBM treatment. Further studies are needed to explore the effectiveness of mitochondrial inhibitors as a targeted therapy for GBM.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Oncology

Collagen type VI-α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells

Xuan-Mei Piao et al.

Summary: COL6A1 and COL6A2 play important roles in the pathogenesis and progression of BCa, inhibiting cell proliferation, inducing G(1) phase cell cycle arrest, regulating signaling pathways, and suppressing the activity of matrix metalloproteinases, ultimately forming a physical barrier to inhibit BCa tumor growth and invasion.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling

Yan Lu et al.

Summary: The study identified LINC00511 as a lncRNA associated with TMZ resistance in GBM, upregulated in resistant cells and correlated with poor prognosis in patients. LINC00511 was found to regulate Wnt/beta-catenin signaling, impacting TMZ sensitivity in GBM cells. These findings suggest LINC00511 as a potential therapeutic target and biomarker for GBM patients.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Article Pharmacology & Pharmacy

A low MW inhibitor of CD44 dimerization for the treatment of glioblastoma

Chongwu Wang et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma

Jingwei Wan et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Cell Biology

Monocyte heterogeneity and functions in cancer

Claire E. Olingy et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond

Shireen R. Lamande et al.

MATRIX BIOLOGY (2018)

Review Oncology

Molecular markers in glioma

Kirsten Ludwig et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Article Medicine, General & Internal

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James R. Perry et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Pharmacology & Pharmacy

Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy

Yang Yi et al.

FRONTIERS IN PHARMACOLOGY (2016)

Article Cell Biology

Different pediatric brain tumors are associated with different gene expression profiling

Michelino Di Rosa et al.

ACTA HISTOCHEMICA (2015)

Article Biochemistry & Molecular Biology

DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells

Daoyang Zhou et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2015)

Article Biochemical Research Methods

Accessibilome of Human Glioblastoma: Collagen-VI-alpha-1 Is a New Target and a Marker of Poor Outcome

Andrei Turtoi et al.

JOURNAL OF PROTEOME RESEARCH (2014)

Article Medicine, Research & Experimental

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours

Jiyoung Park et al.

EMBO MOLECULAR MEDICINE (2013)

Article Biochemistry & Molecular Biology

COL6A3 Protein Deficiency in Mice Leads to Muscle and Tendon Defects Similar to Human Collagen VI Congenital Muscular Dystrophy

Te-Cheng Pan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Oncology

Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15

Xing-gang Mao et al.

TRANSLATIONAL ONCOLOGY (2009)

Review Clinical Neurology

Epidemiology and molecular pathology of glioma

Judith A. Schwartzbaum et al.

NATURE CLINICAL PRACTICE NEUROLOGY (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Multidisciplinary Sciences

Identification of human brain tumour initiating cells

SK Singh et al.

NATURE (2004)

Review Multidisciplinary Sciences

Stem cells, cancer, and cancer stem cells

T Reya et al.

NATURE (2001)